Big data: It is expected to complete gene sequencing within 24 hours by 2020
Recently, at the 2016 Intel Life Science Information Technology Forum, a bio-computing acceleration platform called GTX One appeared, which triggered a new view of the precision medical industry. This GTX One acceleration system fully releases the computing power of the FPGA through algorithm innovation, which is equivalent to compressing a supercomputer into a small box; an FPGA accelerator card can achieve the calculation of 60 high-performance Xeon CPU servers. Performance greatly reduces the computational time of bioinformatics data. In fact, through biometric data in conjunction with the medical industry, bio-medical industry is undergoing rapid development. The "Intel BioIT Partners" launched by Intel in Beijing is expected to complete a series of precise medical procedures such as gene sequencing -medical analysis-medical solutions within 24 hours by 2020. Precision medicine and gene sequencing are breaking out In the next five years, the scale of the global precision medical market will grow rapidly. According to the Southwest Securities Research Report, the global precision medical market is nearly 60 billion US dollars in 2015, and the growth rate can reach 15% during 2015-2020, which is the growth rate of the pharmaceutical industry. 3-4 times; the gene sequencing market in 2013 is about 4.5 billion US dollars, with a compound growth rate of 21.2% in 2013-2018, while China and India have a compound growth rate of 20-25% in 2012-2017. From the perspective of medical technology, precision medicine is inseparable from gene sequencing, and there is a close relationship between the two. As for the rapid development of precision medicine on a global scale, it is mainly due to the following three factors. 1. Strong support in policy. Last year, US President Barack Obama announced in his 2015 State of the Union address that he would focus on supporting the development of precision medicine, investing $215 million in database and genetic screening. In China, favorable policies for precision medicine have also appeared frequently. The Ministry of Science and Technology even held the first national expert meeting on precision medicine strategy, and plans to invest 60 billion yuan in precision medicine by 2030. The favorable news on the policy has greatly stimulated the investment of human and financial resources by relevant enterprises and medical institutions to develop accurate medical care. 2. The rise of genetic testing technology has greatly promoted the rapid development of precision medicine. Compared with traditional medical technology, precision medicine is not limited to the treatment of diseases. It has higher accuracy and efficiency in reducing the incidence of diseases and effectively preventing and treating patients' conditions. 3. With the continuous improvement of the income level of living, the people are paying more and more attention to their own health. Especially for China, which is entering the aging population, medical problems are becoming an increasingly important issue in the whole society. The demand for precision medicine is also rising. Sweetener Aspartame,Sweetener For Food,Food Ingredients Aspartame,Sweeteners In Food Additives CHANGZHOU GUANGHUI FOOD INGREDIENTS CO.,LTD , https://www.gsweetfood.com